Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in a Patient with Chronic Hepatitis B Virus Infection: Case Report and Summary of the Literat...

por Yamashita, Yuki, Joshita, Satoru, Kobayashi, Hiroyuki, Wakabayashi, Shun-ichi, Sugiura, Ayumi, Yamazaki, Tomoo, Umemura, Takeji
Publicado 2021

Investigation of the Effect of KIR–HLA Pairs on Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients

por Umemura, Takeji, Joshita, Satoru, Saito, Hiromi, Wakabayashi, Shun-ichi, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Ota, Masao
Publicado 2021

Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients

por Joshita, Satoru, Ota, Masao, Kobayashi, Hiroyuki, Wakabayashi, Shun-ichi, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Tanaka, Eiji, Umemura, Takeji
Publicado 2021

Pyogenic liver abscess associated with Klebsiella oxytoca: Mimicking invasive liver abscess syndrome

por Iwadare, Takanobu, Kimura, Takefumi, Sugiura, Ayumi, Takei, Risa, Kamakura, Masato, Wakabayashi, Shun-ichi, Okumura, Taiki, Hara, Daichi, Nakamura, Akira, Umemura, Takeji
Publicado 2023

Protocol: Prospective observational study investigating the prevalence and clinical outcome of portopulmonary hypertension in Japanese patients with chronic liver disease

por Wakabayashi, Shun-ichi, Joshita, Satoru, Kimura, Kazuhiro, Motoki, Hirohiko, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Kuwahara, Koichiro, Umemura, Takeji
Publicado 2021

Symptom‐based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease

por Wakabayashi, Shun‐Ichi, Joshita, Satoru, Kimura, Kazuhiro, Motoki, Hirohiko, Okumura, Taiki, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Kimura, Takefumi, Kuwahara, Koichiro, Umemura, Takeji
Publicado 2023

Higher Responsiveness for Women, High Transaminase Levels, and Fat Percentage to Pemafibrate Treatment for NAFLD

por Iwadare, Takanobu, Kimura, Takefumi, Kunimoto, Hideo, Tanaka, Naoki, Wakabayashi, Shun-ichi, Yamazaki, Tomoo, Okumura, Taiki, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Joshita, Satoru, Umemura, Takeji
Publicado 2022

Prognostic Significance of C-Reactive Protein in Lenvatinib-Treated Unresectable Hepatocellular Carcinoma: A Multi-Institutional Study

por Okumura, Taiki, Kimura, Takefumi, Iwadare, Takanobu, Wakabayashi, Shun-ichi, Kobayashi, Hiroyuki, Yamashita, Yuki, Sugiura, Ayumi, Joshita, Satoru, Fujimori, Naoyuki, Kunimoto, Hideo, Komatsu, Michiharu, Fukushima, Hideki, Mori, Hiromitsu, Umemura, Takeji
Publicado 2023

Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients

por Iwadare, Takanobu, Kimura, Takefumi, Tanaka, Naoki, Yamazaki, Tomoo, Wakabayashi, Shun-ichi, Okumura, Taiki, Kobayashi, Hiroyuki, Yamashita, Yuki, Pydi, Sai P., Nakajima, Tomoyuki, Iwaya, Mai, Sugiura, Ayumi, Joshita, Satoru, Uehara, Takeshi, Umemura, Takeji
Publicado 2022

Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project

por Kobayashi, Hiroyuki, Joshita, Satoru, Akahane, Yuki, Matsuzaki, Katsuhiko, Yamada, Hiromi, Aomura, Daiki, Joshita, Nao, Midorikawa, Hajime, Suyama, Kazuhiro, Ota, Masao, Wakabayashi, Shun-ichi, Yamashita, Yuki, Sugiura, Ayumi, Yamazaki, Tomoo, Misawa, Hiromichi, Umemura, Takeji
Publicado 2021